GT Biopharma (GTBP)
(Delayed Data from NSDQ)
$1.77 USD
-0.01 (-0.56%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $1.74 -0.03 (-1.69%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
GT Biopharma, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GTBP 1.77 -0.01(-0.56%)
Will GTBP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GTBP based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for GTBP
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
GT Biopharma (GTBP) Enhances Board with New Appointment | GTBP Stock News
GT Biopharma Appoints New Member to its Board of Directors | GTBP Stock News